EII:FRA
Eisai Co Ltd
€28.40
arrow_upward
+1.39%(+0.39) 1D
Nov 12, 5:10:47 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EII...
Open
€28.69
High
€28.69
Low
€28.40
Mkt. cap
9.75B
Avg. vol.
239.00
Volume
54.00
52-wk high
€31.02
52-wk low
€19.70
No. of employees
11K
Open
€28.69
High
€28.69
Low
€28.40
Mkt. cap
9.75B
Avg. vol.
239.00
Volume
54.00
52-wk high
€31.02
52-wk low
€19.70
No. of employees
11K
News stories
From web sources and news partners
finance.biggo.com
·
1 day ago
[Eisai FY2026 Q2 Earnings Call] Eisai Posts 20.4% Rise in Interim Operating Profit to ¥41.4 Billion - Subcutaneous Leqembi Winning Patients at 4x the Pace of IV; Full-Year ¥70 Billion Target "Aiming for Upside"
Investing.com
·
2 days ago
Eisai Q2 FY2026 slides: 3L products drive 17.5% revenue growth
Investing.com
·
2 days ago
Earnings call transcript: Eisai posts strong Q2 2026 growth, stock slips
Profile
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
About Eisai Co Ltd
CEOHaruo Naito | Haruo Naito
Employees10.5K
FoundedDec 6, 1941
HeadquartersBunkyo City, Tokyo, Japan
SectorHealth Care
IndustryPharmaceutical industry
Websiteeisai.co.jp